Publisher: Elsevier
ISSN: 1050-1738
Source: Trends in Cardiovascular Medicine, Vol.10, Iss.4, 2000-05, pp. : 143-148
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Yilmaz A. Reiss C. Tantawi O. Weng A. Stumpf C. Raaz D. Ludwig J. Berger T. Steinkasserer A. Daniel W.G. Garlichs C.D.
Atherosclerosis, Vol. 172, Iss. 1, 2004-01 ,pp. :
Advantages of Lipid-Lowering Therapy in Cerebral Ischemia: Role of HMG-CoA Reductase Inhibitors
Cerebrovascular Diseases, Vol. 11, Iss. 1, 2010-04 ,pp. :
Recent Patents on Cardiovascular Drug Discovery, Vol. 5, Iss. 2, 2010-06 ,pp. :
HMG-CoA reductase inhibitor pharmacogenomics: overview and implications for practice
By Zineh Issam
Future Cardiology, Vol. 1, Iss. 2, 2005-03 ,pp. :